 effect naproxen sulindac blood pressur respons twenty-eight patient mild essenti hypertens atenolol five-week double-blind placebo-control trial effect sulindac naproxen blood pressur BP control atenolol week naproxen sulindac atenolol week crossov week data patient skin rash naproxen systol BP placebo mean mm Hg percent confid interv signific differ systol BP sulindac administr placebo naproxen signific effect diastol BP weight naproxen sulindac placebo mean kg signific extent one-week therapi naproxen potenti sulindac systol BP well-control hypertens patient atenolol increas minor unlik clinic signific